146 related articles for article (PubMed ID: 37986213)
1. Meta-analysis: Impact of intragastric balloon therapy on NAFLD-related parameters in patients with obesity.
Aoko O; Maharaj T; Boland F; Cheriyan D; Ryan J
Aliment Pharmacol Ther; 2024 Jan; 59(1):8-22. PubMed ID: 37986213
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Intragastric Balloon (IGB) in Non-alcoholic Fatty Liver Disease (NAFLD): a Comprehensive Review and Meta-analysis.
Chandan S; Mohan BP; Khan SR; Facciorusso A; Ramai D; Kassab LL; Bhogal N; Asokkumar R; Lopez-Nava G; McDonough S; Adler DG
Obes Surg; 2021 Mar; 31(3):1271-1279. PubMed ID: 33409973
[TBL] [Abstract][Full Text] [Related]
3. Effect of Intragastric Balloons on Liver Enzymes: A Systematic Review and Meta-Analysis.
Popov VB; Thompson CC; Kumar N; Ciarleglio MM; Deng Y; Laine L
Dig Dis Sci; 2016 Sep; 61(9):2477-87. PubMed ID: 27207181
[TBL] [Abstract][Full Text] [Related]
4. Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis.
Bazerbachi F; Vargas EJ; Rizk M; Maselli DB; Mounajjed T; Venkatesh SK; Watt KD; Port JD; Basu R; Acosta A; Hanouneh I; Gara N; Shah M; Mundi M; Clark M; Grothe K; Storm AC; Levy MJ; Abu Dayyeh BK
Clin Gastroenterol Hepatol; 2021 Jan; 19(1):146-154.e4. PubMed ID: 32360804
[TBL] [Abstract][Full Text] [Related]
5. Bariatric and metabolic endoscopy in the handling of fatty liver disease. A new emerging approach?
Espinet Coll E; Vila Lolo C; Díaz Galán P; Gómez Valero JA; Bacchiddu S; Quintana Tomás C; Irigoyen D; Gunnard K; Juan-Creix Comamala A
Rev Esp Enferm Dig; 2019 Apr; 111(4):283-293. PubMed ID: 30896957
[TBL] [Abstract][Full Text] [Related]
6. Intragastric Balloon Treatment for Obesity: Review of Recent Studies.
Tate CM; Geliebter A
Adv Ther; 2017 Aug; 34(8):1859-1875. PubMed ID: 28707286
[TBL] [Abstract][Full Text] [Related]
7. Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis.
Salomone F; Currenti W; Magrì G; Boškoski I; Zelber-Sagi S; Galvano F
Liver Int; 2021 Sep; 41(9):2112-2116. PubMed ID: 33938630
[TBL] [Abstract][Full Text] [Related]
8. Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre.
Nguyen V; Li J; Gan J; Cordero P; Ray S; Solis-Cuevas A; Khatib M; Oben JA
Can J Gastroenterol Hepatol; 2017; 2017():4697194. PubMed ID: 29441342
[TBL] [Abstract][Full Text] [Related]
9. Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
Jirapinyo P; McCarty TR; Dolan RD; Shah R; Thompson CC
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):511-524.e1. PubMed ID: 33727164
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic Bariatric Interventions in Patients with Chronic Liver Disease.
Bustamante-Bernal MA; Chavez LO; Zuckerman MJ
Clin Liver Dis; 2022 Feb; 26(1):139-148. PubMed ID: 34802660
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Age, Gender, and Baseline BMI on Weight Loss Outcomes in Obese Patients Undergoing Intragastric Balloon Therapy.
Diab AF; Abdurasul EM; Diab FH
Obes Surg; 2019 Nov; 29(11):3542-3546. PubMed ID: 31267474
[TBL] [Abstract][Full Text] [Related]
12. Psychological Aspects of Treatment with Intragastric Balloon for Management of Obesity: A Systematic Review of the Literature.
Pietrabissa G; Bertuzzi V; Simpson S; Guerrini Usubini A; Cattivelli R; Bertoli S; Mozzi E; Roviaro G; Castelnuovo G; Molinari E
Obes Facts; 2022; 15(1):1-18. PubMed ID: 34818229
[TBL] [Abstract][Full Text] [Related]
13. Intragastric Balloon as Bridging Therapy Prior to Bariatric Surgery for Patients with Severe Obesity (BMI ≥ 50 kg/m
Loo JH; Lim YH; Seah HL; Chong AZQ; Tay KV
Obes Surg; 2022 Feb; 32(2):489-502. PubMed ID: 34787766
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the safety of intragastric balloon: An analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program.
Dang JT; Switzer NJ; Sun WYL; Raghavji F; Birch DW; Karmali S
Surg Obes Relat Dis; 2018 Sep; 14(9):1340-1347. PubMed ID: 29934235
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives.
Salomone F; Sharaiha RZ; Boškoski I
Liver Int; 2020 Jun; 40(6):1262-1268. PubMed ID: 32181573
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Intragastric Balloons in the Markers of Metabolic Dysfunction-associated Fatty Liver Disease: Results from Meta-analyses.
Zou ZY; Zeng J; Ren TY; Shi YW; Yang RX; Fan JG
J Clin Transl Hepatol; 2021 Jun; 9(3):353-363. PubMed ID: 34221921
[TBL] [Abstract][Full Text] [Related]
17. Fluid-filled intragastric balloons are an effective and safe weight loss option across BMI and age ranges.
Marrero Torres RJ; Gregory F; Micames CG
Surg Endosc; 2022 Jul; 36(7):5160-5166. PubMed ID: 34845556
[TBL] [Abstract][Full Text] [Related]
18. Intragastric balloon outcomes in super-obesity: a 16-year city center hospital series.
Ashrafian H; Monnich M; Braby TS; Smellie J; Bonanomi G; Efthimiou E
Surg Obes Relat Dis; 2018 Nov; 14(11):1691-1699. PubMed ID: 30193905
[TBL] [Abstract][Full Text] [Related]
19. Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients.
Ricci G; Bersani G; Rossi A; Pigò F; De Fabritiis G; Alvisi V
Obes Surg; 2008 Nov; 18(11):1438-42. PubMed ID: 18369681
[TBL] [Abstract][Full Text] [Related]
20. Intragastric Balloon Significantly Improves Metabolic Parameters at 6 Months: a Meta-Analysis.
Shah RH; Vedantam S; Kumar S; Amin S; Pearlman M; Bhalla S
Obes Surg; 2023 Mar; 33(3):725-732. PubMed ID: 36633759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
